pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vaccine · news · pharmadog
← back to Vaccine
News · Vaccine
688
stories
Sep 14, 26
Judge blocks Trump administration plans to limit visa length for grad students, postdocs
stat
Sep 14, 26
Abbott agrees to settlement over closure of largest baby formula plant in the U.S.
stat
Sep 14, 26
Kennedy to deliver keynote for anti-vaccine group he once led
stat
Sep 14, 26
Pennsylvania officials report state’s third death involving measles
stat
Sep 14, 26
Pennsylvania records third measles-related death amid outbreak
stat
Sep 14, 26
Opinion: Restoring public trust in science doesn’t have a simple solution. That’s OK
stat
Sep 14, 26
Opinion: Am I a hypocrite for loving football despite CTE?
stat
Sep 14, 26
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
biospace
Sep 14, 26
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
Sep 11, 26
Medicaid will let states use ‘tiers’ to determine medical frailty
stat
Sep 11, 26
Frazier adds $1.1B+ to small and mid-sized biotech fund
biospace
Sep 11, 26
mRNA cancer vaccines’ biggest barriers to market
biopharma dive
Sep 11, 26
Boycott launched against American Diabetes Association includes journal
stat
Sep 11, 26
Opinion: I’m a thoracic surgeon in New York City. For many of my patients, Sept. 11 is still not over
stat
Sep 11, 26
Opinion: I’m a public health communications consultant. Pro-vaccine advocacy needs more fun
stat
Sep 11, 26
STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGs
stat
Sep 10, 26
Andy Plump, architect of Takeda’s R&D overhaul, to retire next year
biopharma dive
Sep 10, 26
Chutes & Ladders—Longtime Takeda R&D chief to depart next June
fiercebiotech
Sep 10, 26
STAT+: FDA expands Bayer lung cancer drug approval
stat
Sep 10, 26
Oz says ‘AI-based avatars’ can help rural communities. Some leaders disagree
stat
Sep 10, 26
STAT+: Five midterm races to watch that could be crucial for vaccine policy
stat
Sep 9, 26
STAT+: Orexin discoverers awarded prestigious Lasker award
stat
Sep 9, 26
Telemedicine company offers GLP-1s for addiction
stat
Sep 9, 26
STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea
stat
Sep 9, 26
Luma locks down 15-year, $410M fund for life science investments
fiercebiotech
Sep 8, 26
STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
stat
Sep 8, 26
Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancer
biospace
Sep 8, 26
Inhibrx targets OX40 agonist-cancer vaccine studies from early next year
endpoints
Sep 8, 26
Opinion: It’s time to take the gloves off during vaccination
stat
Sep 8, 26
Moderna and Merck’s mRNA success fuels focus on ‘scaling out and scaling down’
biospace
← prev
page 10 of 23
next →